Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Jan Brase
Introduction
Jan Brase is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of medical science, particularly in oncology. His work focuses on improving chemotherapy regimens for patients suffering from breast cancer.
Latest Patents
Jan Brase holds a patent for a method that predicts the benefit of including taxane in chemotherapy for breast cancer patients. This innovative method involves determining the expression levels of the marker genes S100P and PCSK6. By mathematically combining these expression level values, a combined score is generated. This score is then compared to a reference value, where a high score indicates a potential benefit from taxane inclusion, while a low score suggests otherwise.
Career Highlights
Throughout his career, Jan Brase has worked with several prominent companies in the medical diagnostics field. Notably, he has been associated with Sividon Diagnostics GmbH and Myriad International GmbH. His expertise and innovative approaches have contributed to advancements in cancer treatment methodologies.
Collaborations
Jan Brase has collaborated with esteemed colleagues such as Ralf Kronenwett and Karin Fisch. These partnerships have further enhanced his research and development efforts in the medical field.
Conclusion
Jan Brase's contributions to the field of oncology through his innovative patent and collaborations highlight his commitment to improving patient outcomes in breast cancer treatment. His work exemplifies the importance of research and innovation in the medical sciences.